Navigation Links
Vioxx Not Safe Even For Short Term Use

Canadian researchers have found that Vioxx painkiller manufactured by Merck & Co would result in an increased risk of heart attack within two weeks after patients start taking the drug. // Statistics show that about 60 patients out of 239 elderly patients suffered from heart attacks within six to 13 days after they first started taking Vioxx. The study results are published in the Canadian Medical Association Journal. It was contrary to what Merck had previously told about the drug. It currently faces 11,500 Vioxx lawsuits. The company has been hit with three jury awards totaling $298.3 million, two of which involved short-term use of the painkiller. It is also associated with the death of a man who took the drug for a period of 30 days.

Linda Levesque, assistant professor of epidemiology at Queen's University in Kingston, Ontario said that it is highly dangerous for the first time users and they might suffer an attack in as little as two weeks. Merck is the fourth-biggest U.S. drug maker. It withdrew Vioxx in 2004 when the drug was proved to double the risk of heart attacks and strokes. It has set aside $970 million for legal costs and vows to fight each case rather than settle out of court. `Cases Easier to Win' Attorney Mark Lanier, the attorney for the drug company has already won two out of the three trials. Canadian researchers analyzed health records of 114,000 patients ages 66 and older who were prescribed painkillers, including Vioxx, Celebrex and ibuprofen. The study followed patients for about two and a half years, included 30,200 Vioxx users and 45,000 Celebrex users. Celebrex was not associated with any heart attacks but when patients started taking Vioxx it significantly increased the risk among patients. But it also diminished. But it is thought that the study would play a major role in contributing to making a better decision by the people.


'"/>




Page: 1

Related medicine news :

1. Increased Heart Attack Risk From Celebrex,Vioxx
2. Merck to pay $ 253.5 million to Vioxx victim family
3. Judgment In Favor Of Merck For Vioxx Drug
4. Could Long Tern Vioxx Users Suffer From Heart Attacks?
5. Doctor Grilled In Court For False Report About Vioxx Health Risk
6. Vioxx and Celebrex, now have alternatives
7. Merck in the Dock Due To Vioxx
8. A Stroke of Bad Luck for Vioxx
9. Arcoxia Slammed –Nothing Better Than Vioxx Says FD
10. Bad News for Short People
11. Painkillers Do Not Shorten Dying Patients Lives
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/17/2017)... ... January 17, 2017 , ... ... companies and ranked among the top US security companies for consecutive years, today ... This announcement brings a year-long independent board nomination process to a close and ...
(Date:1/17/2017)... (PRWEB) , ... January 17, 2017 , ... ... Center and the Montclair State University’s Athletic Training Education program forged a relationship ... Athletic Training Education Program, which is consists of both student members and ...
(Date:1/16/2017)... ... ... California Southern University has named Dr. Steven Beazley University President. ... a core faculty member, teaching master’s and doctoral courses in the university’s School of ... where he earned his Doctor of Psychology degree in 1998. Dr. Beazley also has ...
(Date:1/16/2017)... ... January 16, 2017 , ... With the Grand Opening Event planned for ... use by sports teams and the general public. Built in five months by Centerpoint, ... be converted into basketball or pickleball courts. The space is also suitable for indoor ...
(Date:1/16/2017)... ... January 16, 2017 , ... As New York’s ... Victor Giamos, MD to their medical staff, according to eye surgeon, Jeffrey Martin, ... Eye Care, a division of SightMD. Dr. Giamos will practice primarily out of ...
Breaking Medicine News(10 mins):
(Date:1/17/2017)... Calif. and KANSAS CITY, ... Children,s Hospitals Neonatal Consortium (CHNC) has selected Velos ... their visionary data management and multicenter initiatives. ... organization comprised of 32 Neonatal Intensive Care Units ... America . The consortium provides a benchmark ...
(Date:1/17/2017)... , Jan. 17, 2016  Attorney Advertising -- Bronstein, Gewirtz ... purchasers of Anthera Pharmaceuticals, Inc. ("Anthera" or the "Company") (NASDAQ: ... additional information and assist the investigation by visiting the firm,s ... Anthera and certain of its officers and/or directors have violated ... 1934. ...
(Date:1/17/2017)...   Tocagen Inc ., a clinical-stage, cancer-selective gene therapy company, ... research and pharmaceutical development at Tocagen, will present at Phacilitate ... 17-20 in Miami . Details ... ... replicating viruses - what to do when and why Date and ...
Breaking Medicine Technology: